How AI Research Agents Are Transforming Life Sciences Intelligence
In the high-stakes arena of drug development and clinical evidence generation, the bottleneck is no longer the availability of data; it is the speed of synthesis. For the past decade, life sciences organizations have invested billions into digitizing real-world data (RWD), scaling bioinformatics pipelines, and implementing Natural Language Processing (NLP) to parse the ever-expanding […]
The Three Pillars of High-Impact AI in Rare Diseases & Oncology
For rare diseases and oncology, where data is scarce and patients are hard to find, the margin for error is razor-thin. We believe achieving success with AI requires a strategic commitment to three core pillars: The Right Data Foundation with Integrated Patient Data™: Finding quality data in Oncology & Rare Diseases has always been a […]
